Scholarlink

Background <p>Chronic obstructive pulmonary disease (COPD) is often associated with systemic inflammation and metabolic dysfunction, including insulin resistance (IR). The triglyceride-to-HDL cholesterol (TG/HDL-C) ratio has emerged as a potential surrogate marker of IR.</p> Purpose <p>The present study aimed to evaluate the TG/HDL-C ratio as a marker of IR in non-diabetic patients with COPD and compare it with the conventional HOMA-IR method.</p> Design <p>This is a hospital-based cross-sectional observational study.</p> Methods <p>The study included 80 non-diabetic patients with COPD aged ≤ 65 years, recruited from a tertiary care center. Patients were assessed for pulmonary function (spirometry) and categorized according to the GOLD criteria. Fasting blood samples were collected to measure lipid profiles, fasting and postprandial blood glucose levels, HbA1c levels, and plasma insulin levels. Correlation analysis was performed to assess the relationship between TG/HDL-C/HDL ratio, HOMA-IR, and clinical parameters.</p> Results <p>The TG/HDL-C ratio showed a strong positive correlation with HOMA-IR (<i>r</i> = 0.669, <i>p</i> &lt; 0.001), indicating its potential as a surrogate marker for IR. The area under the ROC curve for the TG/HDL-C ratio demonstrated high diagnostic accuracy, with a steep rise towards the top-left corner, reflecting high sensitivity and specificity. Age, smoking status, and disease severity (GOLD stage) were also positively associated with higher TG/HDL ratios in the present study.</p> Conclusion <p>The TG/HDL ratio is a simple, cost-effective surrogate marker for identifying IR in non-diabetic patients with COPD, offering a practical alternative to HOMA-IR for routine clinical use. Further studies are recommended to validate these findings in larger and more diverse populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of TG/ HDL ratio as a marker for insulin resistance in non-diabetic COPD patients: a comparative study with homeostasis model assessment for insulin resistance

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月2日

查看全文
  • Mahesh Mahadevaiah,
  • Phanindra Babu,
  • Manjula Shivanagappa,
  • Vidya G Doddawad

摘要

Background

Chronic obstructive pulmonary disease (COPD) is often associated with systemic inflammation and metabolic dysfunction, including insulin resistance (IR). The triglyceride-to-HDL cholesterol (TG/HDL-C) ratio has emerged as a potential surrogate marker of IR.

Purpose

The present study aimed to evaluate the TG/HDL-C ratio as a marker of IR in non-diabetic patients with COPD and compare it with the conventional HOMA-IR method.

Design

This is a hospital-based cross-sectional observational study.

Methods

The study included 80 non-diabetic patients with COPD aged ≤ 65 years, recruited from a tertiary care center. Patients were assessed for pulmonary function (spirometry) and categorized according to the GOLD criteria. Fasting blood samples were collected to measure lipid profiles, fasting and postprandial blood glucose levels, HbA1c levels, and plasma insulin levels. Correlation analysis was performed to assess the relationship between TG/HDL-C/HDL ratio, HOMA-IR, and clinical parameters.

Results

The TG/HDL-C ratio showed a strong positive correlation with HOMA-IR (r = 0.669, p < 0.001), indicating its potential as a surrogate marker for IR. The area under the ROC curve for the TG/HDL-C ratio demonstrated high diagnostic accuracy, with a steep rise towards the top-left corner, reflecting high sensitivity and specificity. Age, smoking status, and disease severity (GOLD stage) were also positively associated with higher TG/HDL ratios in the present study.

Conclusion

The TG/HDL ratio is a simple, cost-effective surrogate marker for identifying IR in non-diabetic patients with COPD, offering a practical alternative to HOMA-IR for routine clinical use. Further studies are recommended to validate these findings in larger and more diverse populations.